Document is current
Any future updates will be listed below
-
Authors
Hegazy, Sahar K.
Hassan, Ahmed H.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05502081 at ClinicalTrials.govDocuments that mention this clinical trial
The effect of combination treatment with casirivimab and imdevimab versus standard antiviral therapy on clinical outcomes in hospitalized COVID-19 patients
https://doi.org/10.1007/s44337-024-00045-3
- License Information
-
More Information
Article History
Received: 9 May 2024
Accepted: 13 August 2024
First Online: 14 October 2024
Declarations
:
: The research protocol was approved by Research ethics committee, ministry of health, Egypt, 10-2022/18. IRB, faculty of medicine, Mansoura University, MS21.11.1737. Research ethics committee, faculty of medicine, Tanta University, 35039/11/21. Registry name and registration number: Clinicaltrials.gov, NCT05502081. Written informed consent was obtained from all participants. The study was performed in accordance with the Helsinki Declaration of 1964, and its later amendments. Written informed consent was obtained from the parent/guardian of each participant under 18 years of age. All subjects provided informed consent to participate in the study.
: Not applicable.
: The authors have no relevant financial or nonfinancial interests to disclose.
